Report cover image

Global Coagulation Factor Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 194 Pages
SKU # APRC20552688

Description

Summary

According to APO Research, The global Coagulation Factor Concentrates market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Coagulation Factor Concentrates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Coagulation Factor Concentrates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Coagulation Factor Concentrates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Coagulation Factor Concentrates is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Coagulation Factor Concentrates include Bio Product Laboratory (UK), Biotest (Germany), CSL (Australia), Green Cross Corporation (South Korea), Grifols (Spain), Japan Blood Products Organization, China Biologic Products (China), Kedrion (Italy), LFB (France) and Octapharma (Switzerland), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Coagulation Factor Concentrates, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Coagulation Factor Concentrates, also provides the sales of main regions and countries. Of the upcoming market potential for Coagulation Factor Concentrates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coagulation Factor Concentrates sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Coagulation Factor Concentrates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Coagulation Factor Concentrates sales, projected growth trends, production technology, application and end-user industry.

Coagulation Factor Concentrates Segment by Company

Bio Product Laboratory (UK)
Biotest (Germany)
CSL (Australia)
Green Cross Corporation (South Korea)
Grifols (Spain)
Japan Blood Products Organization, China Biologic Products (China)
Kedrion (Italy)
LFB (France)
Octapharma (Switzerland)
Sanquin (Netherlands)
Shire (Ireland)
Shanghai RAAS Blood Products (China)
Coagulation Factor Concentrates Segment by Type

Factor XIII
Factor VIII
Factor IX
Fibrinogen Concentrates
Prothrombin Complex Concentrates
Von Willebrand Factor
Coagulation Factor Concentrates Segment by Application

Pulmonology
Rheumatology
Immunology
Neurology
Hematology
Hemato-Oncology
Critical Care
Others
Coagulation Factor Concentrates Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor Concentrates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coagulation Factor Concentrates market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Coagulation Factor Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coagulation Factor Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Coagulation Factor Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Coagulation Factor Concentrates Market Size, 2020 VS 2024 VS 2031
1.3 Global Coagulation Factor Concentrates Market Size Estimates and Forecasts (2020-2031)
1.4 Global Coagulation Factor Concentrates Sales Estimates and Forecasts (2020-2031)
1.5 Global Coagulation Factor Concentrates Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Coagulation Factor Concentrates Market Dynamics
2.1 Coagulation Factor Concentrates Industry Trends
2.2 Coagulation Factor Concentrates Industry Drivers
2.3 Coagulation Factor Concentrates Industry Opportunities and Challenges
2.4 Coagulation Factor Concentrates Industry Restraints
3 Coagulation Factor Concentrates Market by Manufacturers
3.1 Global Coagulation Factor Concentrates Revenue by Manufacturers (2020-2025)
3.2 Global Coagulation Factor Concentrates Sales by Manufacturers (2020-2025)
3.3 Global Coagulation Factor Concentrates Average Sales Price by Manufacturers (2020-2025)
3.4 Global Coagulation Factor Concentrates Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Coagulation Factor Concentrates Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Coagulation Factor Concentrates Manufacturers, Product Type & Application
3.7 Global Coagulation Factor Concentrates Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Coagulation Factor Concentrates Market CR5 and HHI
3.8.2 Global Top 5 and 10 Coagulation Factor Concentrates Players Market Share by Revenue in 2024
3.8.3 2024 Coagulation Factor Concentrates Tier 1, Tier 2, and Tier 3
4 Coagulation Factor Concentrates Market by Type
4.1 Coagulation Factor Concentrates Type Introduction
4.1.1 Factor XIII
4.1.2 Factor VIII
4.1.3 Factor IX
4.1.4 Fibrinogen Concentrates
4.1.5 Prothrombin Complex Concentrates
4.1.6 Von Willebrand Factor
4.2 Global Coagulation Factor Concentrates Sales by Type
4.2.1 Global Coagulation Factor Concentrates Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Coagulation Factor Concentrates Sales by Type (2020-2031)
4.2.3 Global Coagulation Factor Concentrates Sales Market Share by Type (2020-2031)
4.3 Global Coagulation Factor Concentrates Revenue by Type
4.3.1 Global Coagulation Factor Concentrates Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Coagulation Factor Concentrates Revenue by Type (2020-2031)
4.3.3 Global Coagulation Factor Concentrates Revenue Market Share by Type (2020-2031)
5 Coagulation Factor Concentrates Market by Application
5.1 Coagulation Factor Concentrates Application Introduction
5.1.1 Pulmonology
5.1.2 Rheumatology
5.1.3 Immunology
5.1.4 Neurology
5.1.5 Hematology
5.1.6 Hemato-Oncology
5.1.7 Critical Care
5.1.8 Others
5.2 Global Coagulation Factor Concentrates Sales by Application
5.2.1 Global Coagulation Factor Concentrates Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Coagulation Factor Concentrates Sales by Application (2020-2031)
5.2.3 Global Coagulation Factor Concentrates Sales Market Share by Application (2020-2031)
5.3 Global Coagulation Factor Concentrates Revenue by Application
5.3.1 Global Coagulation Factor Concentrates Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Coagulation Factor Concentrates Revenue by Application (2020-2031)
5.3.3 Global Coagulation Factor Concentrates Revenue Market Share by Application (2020-2031)
6 Global Coagulation Factor Concentrates Sales by Region
6.1 Global Coagulation Factor Concentrates Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Coagulation Factor Concentrates Sales by Region (2020-2031)
6.2.1 Global Coagulation Factor Concentrates Sales by Region (2020-2025)
6.2.2 Global Coagulation Factor Concentrates Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Coagulation Factor Concentrates Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Coagulation Factor Concentrates Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Coagulation Factor Concentrates Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Coagulation Factor Concentrates Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Coagulation Factor Concentrates Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Coagulation Factor Concentrates Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Coagulation Factor Concentrates Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Coagulation Factor Concentrates Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Coagulation Factor Concentrates Revenue by Region
7.1 Global Coagulation Factor Concentrates Revenue by Region
7.1.1 Global Coagulation Factor Concentrates Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Coagulation Factor Concentrates Revenue by Region (2020-2025)
7.1.3 Global Coagulation Factor Concentrates Revenue by Region (2026-2031)
7.1.4 Global Coagulation Factor Concentrates Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Coagulation Factor Concentrates Revenue (2020-2031)
7.2.2 North America Coagulation Factor Concentrates Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Coagulation Factor Concentrates Revenue (2020-2031)
7.3.2 Europe Coagulation Factor Concentrates Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Coagulation Factor Concentrates Revenue (2020-2031)
7.4.2 Asia-Pacific Coagulation Factor Concentrates Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Coagulation Factor Concentrates Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Coagulation Factor Concentrates Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Bio Product Laboratory (UK)
8.1.1 Bio Product Laboratory (UK) Comapny Information
8.1.2 Bio Product Laboratory (UK) Business Overview
8.1.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
8.1.5 Bio Product Laboratory (UK) Recent Developments
8.2 Biotest (Germany)
8.2.1 Biotest (Germany) Comapny Information
8.2.2 Biotest (Germany) Business Overview
8.2.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
8.2.5 Biotest (Germany) Recent Developments
8.3 CSL (Australia)
8.3.1 CSL (Australia) Comapny Information
8.3.2 CSL (Australia) Business Overview
8.3.3 CSL (Australia) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
8.3.5 CSL (Australia) Recent Developments
8.4 Green Cross Corporation (South Korea)
8.4.1 Green Cross Corporation (South Korea) Comapny Information
8.4.2 Green Cross Corporation (South Korea) Business Overview
8.4.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
8.4.5 Green Cross Corporation (South Korea) Recent Developments
8.5 Grifols (Spain)
8.5.1 Grifols (Spain) Comapny Information
8.5.2 Grifols (Spain) Business Overview
8.5.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
8.5.5 Grifols (Spain) Recent Developments
8.6 Japan Blood Products Organization, China Biologic Products (China)
8.6.1 Japan Blood Products Organization, China Biologic Products (China) Comapny Information
8.6.2 Japan Blood Products Organization, China Biologic Products (China) Business Overview
8.6.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
8.6.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments
8.7 Kedrion (Italy)
8.7.1 Kedrion (Italy) Comapny Information
8.7.2 Kedrion (Italy) Business Overview
8.7.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
8.7.5 Kedrion (Italy) Recent Developments
8.8 LFB (France)
8.8.1 LFB (France) Comapny Information
8.8.2 LFB (France) Business Overview
8.8.3 LFB (France) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
8.8.5 LFB (France) Recent Developments
8.9 Octapharma (Switzerland)
8.9.1 Octapharma (Switzerland) Comapny Information
8.9.2 Octapharma (Switzerland) Business Overview
8.9.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
8.9.5 Octapharma (Switzerland) Recent Developments
8.10 Sanquin (Netherlands)
8.10.1 Sanquin (Netherlands) Comapny Information
8.10.2 Sanquin (Netherlands) Business Overview
8.10.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
8.10.5 Sanquin (Netherlands) Recent Developments
8.11 Shire (Ireland)
8.11.1 Shire (Ireland) Comapny Information
8.11.2 Shire (Ireland) Business Overview
8.11.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
8.11.5 Shire (Ireland) Recent Developments
8.12 Shanghai RAAS Blood Products (China)
8.12.1 Shanghai RAAS Blood Products (China) Comapny Information
8.12.2 Shanghai RAAS Blood Products (China) Business Overview
8.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
8.12.5 Shanghai RAAS Blood Products (China) Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Coagulation Factor Concentrates Value Chain Analysis
9.1.1 Coagulation Factor Concentrates Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Coagulation Factor Concentrates Production Mode & Process
9.2 Coagulation Factor Concentrates Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Coagulation Factor Concentrates Distributors
9.2.3 Coagulation Factor Concentrates Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.